Is a
Patent attributes
Patent Applicant
Patent Jurisdiction
Patent Number
Date of Patent
April 27, 2021
Patent Application Number
15032581
Date Filed
October 31, 2014
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention provides for hybrid nuclease-albumin molecules with increased pharmacokinetic properties. The hybrid nuclease-albumin molecules of the invention have one or more nuclease domains (e.g., an RNase and/or DNase domain) operably coupled to an albumin, or a variant or fragment thereof. The invention also provides methods of treating or preventing a condition associated with an abnormal immune response.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
